Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
China Lung Cancer Screening (CLUS) Study Version 3.0
Where
Shanghai
Age
45 years to 75 years
People
100,000
Run by
Shanghai Chest Hospital
See details and how to joinNCT05494021
Phase 1Taking people
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
Where
Tianjin
Age
18 years and over
People
15
Run by
Suzhou BlueHorse Therapeutics Co., Ltd.
See details and how to joinNCT05366478
Phase 1/2Taking people
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
Where
Baoding, Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Jinan, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Tianjin, Wuhan, Zhengzhou
Age
18 years to 80 years
People
183 worldwide
Run by
Haihe Biopharma Co., Ltd.
See details and how to joinNCT04270591
Phase 3Taking people
A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer
Where
Ji'nan
Age
18 years and over
People
150
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT04951635
No phaseNot yet taking people in China
The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer
Where
Beijing
Age
18 years to 80 years
People
180
Run by
Peking University Third Hospital
See details and how to joinNCT05411809
No phaseTaking people
Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field
Where
Nanjing
Age
18 years to 75 years
People
1,120
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT04944563
No phaseTaking people
MRD Monitoring in Lung Cancer After Resection
Where
Guangzhou
Age
18 years and over
People
300
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT04976296
Phase 3Enrolling by invitation
Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection
Where
Beijing, Changsha, Chendu, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Kunming, Nanchang, Nanjing, Ningbo, Qingdao, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Sichuan, Suzhou, Taiyuan, Tianjin, Ürümqi, Weifang, Wenzhou, Wuhan, Xi'an, Zhengzhou
Age
18 years to 130 years
People
606
Run by
Chinese Academy of Medical Sciences
See details and how to joinNCT04762459
Phase 2Not yet taking people in China
Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma
Where
Shenyang
Age
18 years to 75 years
People
45
Run by
Liaoning Cancer Hospital & Institute
See details and how to joinNCT05132985
Phase 3Taking people
A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC
Where
Beijing, Chengdu, Guangzhou, Hangzhou, Nanjing, Shanghai, Zhengzhou
Age
18 years to 70 years
People
537
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT04316364
Phase 2Taking people
A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
Where
Beijing
Age
18 years to 75 years
People
27
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT05104788
Phase 2Taking people
Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial
Where
Shanghai
Age
18 years to 79 years
People
146
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT05053802
Phase 2Taking people
A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules
Where
Shanghai
Age
18 years to 85 years
People
120
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT04905056
Phase 3Taking people
Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy
Where
Jinan
Age
18 years to 75 years
People
534
Run by
Shandong Cancer Hospital and Institute
See details and how to joinNCT04829708
Phase 2Not yet taking people in China
Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)
Where
Nanchang
Age
18 years to 70 years
People
90
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT04846634
No phaseTaking people
The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China
Where
Guangzhou
Age
18 years and over
People
100
Run by
Guangdong Association of Clinical Trials
See details and how to joinNCT04286841
Phase 2Taking people
Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors
Where
Shanghai
Age
18 years to 85 years
People
100
Run by
RenJi Hospital
See details and how to joinNCT03392233
Phase 2Taking people
Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%
Where
Shanghai
Age
19 years to 70 years
People
460
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT03351842
No phaseTaking people
Integrative Analysis of Large-cell Lung Cancer
Where
Ganzhou, Shanghai
Age
18 years to 75 years
People
1,000
Run by
Shanghai 10th People's Hospital
See details and how to joinNCT02917369